Medications

FDA: Omontys injection pulled from market

(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis patients, following ...

Diseases, Conditions, Syndromes

Many older patients initiating dialysis experience functional decline

A new study published in CJASN found that functional decline within the first 6 months after initiating dialysis was highly prevalent in older adults at 17 centers in Netherlands, and the risk was higher in those with advanced ...

Diseases, Conditions, Syndromes

Home dialysis gains momentum

Of the 400,000 people on dialysis in the United States only 6 percent to 7 percent are treated with home dialysis. Yet, patients are significantly more likely to choose home dialysis if they are given that option. Home dialysis ...

Diseases, Conditions, Syndromes

Research shows racial disparities in pregnant women on dialysis

Pregnancy is not common in women on dialysis due to impaired fertility. New research from the University of Cincinnati finds that among patients with certain kidney disease there is a racial disparity as to who is more likely ...

Diseases, Conditions, Syndromes

Researchers study palliative care preferences of Latinos on dialysis

The cultural values of Latinos have a major impact on their palliative care preferences and healthcare providers should be sensitive to their perspectives, according to a research letter by physicians at the University of ...

page 4 from 7